NCT01315171

Brief Summary

Insulin treatment often causes the blood glucose levels to fall too low (hypoglycemia). Hypoglycemia can be associated with confusion and disorientation as well as other symptoms such as palpitations, sweating and tremors. Medium chain triglycerides (MCT) can be used as a fuel in the brain during low blood sugar levels and therefore may prevent or reduce some of the confusion and disorientation seen during hypoglycemia. We would like to determine if a diet supplemented with medium chain triglycerides can improve cognitive function during hypoglycemia, diabetes control and also look at brain activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 15, 2011

Completed
10 months until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

January 17, 2018

Status Verified

January 1, 2018

Enrollment Period

3.6 years

First QC Date

March 11, 2011

Last Update Submit

January 12, 2018

Conditions

Keywords

medium chain triglycerideshypoglycemiacognitive functionfunctional MRI

Outcome Measures

Primary Outcomes (1)

  • Cognitive function tests

    Cognitive function will be assessed during hypoglycemia. 3 tests will be carried looking at working memory with number and word recollection.

    100 minutes

Secondary Outcomes (1)

  • Brain activity

    100 minutes

Study Arms (2)

Medium chain supplemented diet

EXPERIMENTAL

Subjects will have a diet during which all meals are supplemented with 4 tablespoons of medium chain triglyceride oil.

Dietary Supplement: Medium chain triglycerides

Standard group

NO INTERVENTION

Subjects will continue with a standard western diabetes diet.

Interventions

Medium chain triglyceridesDIETARY_SUPPLEMENT

4 tablespoons/day for 2 weeks

Medium chain supplemented diet

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • type 1 diabetes
  • HbA1c \<8%
  • BMI 18-30
  • hypo unawareness

You may not qualify if:

  • pregnancy
  • significant diabetes complications
  • liver disease, cirrhosis
  • cardiac disease
  • neurological disorder
  • kidney disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University School of Medicine

New Haven, Connecticut, 06511, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Hypoglycemia

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Robert Sherwin, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2011

First Posted

March 15, 2011

Study Start

January 1, 2012

Primary Completion

August 1, 2015

Study Completion

October 1, 2016

Last Updated

January 17, 2018

Record last verified: 2018-01

Locations